|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | All cause death | Major bleeding |
---|
|
COMMIT, 2005 NCT | clopidogrel | placebo | | | Low risk of bias | suggesting | | |
CURE (PCI sub study), 2001 | clopidogrel | placebo | | | Low risk of bias | - | | |
CLARITY-TIMI 28, 2005 | clopidogrel | placebo | | | Low risk of bias | - | | |
CURE, 2001 | clopidogrel + aspirin | aspirin | | | Low risk of bias | suggesting | | |
CURRENT OASIS 7 (clopidogrel), 2010 NCT | clopidogrel high-dose regimen | clopidogrel standard-dose | | | Low risk of bias | negative | | |
|
COMMIT, 2005 NCT | clopidogrel | placebo | | | Low risk of bias | suggesting | | |
CLARITY-TIMI 28, 2005 | clopidogrel | placebo | | | Low risk of bias | - | | |
|
ACTIVE W, 2006 NCT | aspirin + clopidogrel | anticoagulant | | | Risk of bias | suggesting | | |
ACTIVE A, 2009 NCT | aspirin + clopidogrel | aspirin | | | Low risk of bias | suggesting | | |
|
CASCADE, 2009 NCT | clopidogrel+aspirin | aspirin | | | Low risk of bias | - | | |
|
CAPRIE (PAD subgroup), 1996 | clopidogrel | aspirin | | | Low risk of bias | suggesting | | |
CAPRIE, 1996 | clopidogrel | aspirin | secondary prevention | | Low risk of bias | suggesting | | |
ASCET NCT | clopidogrel | aspirin | | | Risk of bias | negative | | |
CHARISMA, 2006 NCT | clopidogrel | placebo (on top aspirin) | secondary prevention | | Low risk of bias | suggesting | | |
|
CAPRIE, 1996 | clopidogrel | aspirin | | | Low risk of bias | - | | |
ASCET NCT | clopidogrel | aspirin | | | Risk of bias | negative | | |
|
REAL-LATE, ZEST-LATE, 2010 NCT | clopidogrel+aspirin | aspirin | | | | negative | | |
GRAVITAS, 2011 NCT | high-dose clopidogrel | normal-dose clopidogrel | | | Risk of bias | negative | | |
Müller, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
CLASSICS, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
TOPPS, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
Piamsomboon, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
|
CAPRIE (PAD subgroup), 1996 | clopidogrel | aspirin | | | Low risk of bias | suggesting | | |
|
CAPRIE, 1996 | clopidogrel | aspirin | | | Low risk of bias | - | | |
|
ASCET NCT | clopidogrel | aspirin | | | Risk of bias | negative | | |
|
REAL-LATE, ZEST-LATE, 2010 NCT | clopidogrel+aspirin | aspirin | | | | negative | | |
GRAVITAS, 2011 NCT | high-dose clopidogrel | normal-dose clopidogrel | | | Risk of bias | negative | | |
Müller, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
CLASSICS, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
TOPPS, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |
Piamsomboon, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | | negative | | |